Alliance Global Partners reiterated coverage on Syros Pharmaceuticals with a new price target

3/5/21 4:01:58 PM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Alliance Global Partners reiterated coverage of Syros Pharmaceuticals with a rating of and set a new price target of $14.00 from $18.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$SYRS

Date	Price Target	Rating	Analyst
9/23/2021	$20.00 → $23.00	Buy	Roth Capital